Iparomlimab and Tuvonralimab (QL1706) Combined With Standard Chemotherapy or Combined With Intraperitoneal Perfusion Chemotherapy and Olaparib as Neoadjuvant Therapy for Advanced Ovarian Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Related studies linked through entity extraction aliases.